Randomized controlled trial of efficacy of mosapride plus omeprazole versus omeprazole alone in therapy of gastroesophageal reflux disease.

Trial Profile

Randomized controlled trial of efficacy of mosapride plus omeprazole versus omeprazole alone in therapy of gastroesophageal reflux disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2012

At a glance

  • Drugs Mosapride (Primary) ; Omeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 May 2012 Results presented at the Digestive Disease Week 2012.
    • 19 May 2011 Primary endpoint 'Frequency-Scale-for-Symptoms-of-GERD' has not been met.
    • 29 Dec 2010 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top